In addition, IgSF11 transcripts were elevated in healthy donors, glioma tissues and PBMCs before surgery compared to PBMCs taken from patients after surgery (p = 0.0233), (p = 0.0055), and (p = 0.0235), respectively (Figure 1A). This evidence concerns the gene IGSF11 and central nervous system cancer.